期刊文献+

^(18)F-FDGPET/CT和CA125在胸腔积液鉴别诊断中的临床意义 被引量:5

Clinical significance of ^(18)F-FDG PET/CT and CA125 in Differential Diagnosis of Pleural Effusion
在线阅读 下载PDF
导出
摘要 目的探讨18F-FDG PET/CT显像和血、胸水CA125检测对胸腔积液鉴别诊断的临床意义。方法 40例胸腔积液患者行18F-FDG PET/CT显像以及血、胸水CA125检测,结合最终病理诊断分组,评价其临床意义。结果血、胸水CA125检测结果在良恶性胸腔积液中不具有显著的统计学差异(P>0.05)。18F-FDG PET/CT显像对胸腔积液鉴别诊断的敏感性为92.3%,特异性为85.7%,ROC曲线下面积为0.890。血CA125检测敏感性为84.6%,特异性为28.6%,ROC曲线下面积为0.566。胸水CA125检测敏感性为100%,特异性为14.3%,ROC曲线下面积为0.571。三项联合检测ROC曲线下面积为0.890。结论18F-FDG PET/CT显像对于胸腔积液的鉴别诊断有较好的临床价值,血、胸水CA125检测不能单独用于胸腔积液鉴别诊断,且与前者联合并不能提高检测敏感性和特异性。 Objective To evaluate the clinical significance of 18F-FDG PET/CT imaging and detection of blood and pleural effusion CA125 in differential diagnosis of pleural effusion.Methods Forty patients with pleural effusion undergone 18F-FDG PET/CT imaging and blood and pleural effusion CA125 testing.Finally the clinical significance was evaluated by pathology diagnosis group.Results Blood and pleural effusion CA125 testing results were not significant in statistical difference between good and malignant pleural effusion(P〉0.05).The sensitivity and specificity of 18F-FDG PET/CT imaging in differential diagnosis of pleural effusion and the area under the ROC curves were respectively 92.3%,85.7% and 0.890,while in blood CA125 testing respectively for 84.6%,28.6% and 0.566,and in the pleural effusion CA125 testing respectively for 100%,14.3% and 0.571.Three united detection area under the ROC curves are 0.890.Conclusions 18F-FDG PET/CT imaging for pleural effusion differential diagnosis has good clinical value.Blood and pleural effusion CA125 testing could not be used for the differential diagnosis,and theycombined with 18F-FDG PET/CT imaging can’t improve the detection sensitivity and specificity.
出处 《临床肺科杂志》 2012年第9期1656-1658,共3页 Journal of Clinical Pulmonary Medicine
关键词 胸腔积液 18F-FDGPET/CT CA125 pleural effusion; 18F-FDG PET/CT; CA125;
作者简介 通讯作者:陈小东,E—mail:xdchen8@hotmail.com
  • 相关文献

参考文献10

  • 1Light RW.Pleural Effusions[J].Medical Clinics of North America?.2011,95(6):1055-1070.
  • 2Porcel JM,Vives M.Etiology and Pleural Fluid Characteristics of Large and Massive Effusions.Chest.2003,124(3):978-983.
  • 3周一平,叶又蓁,孙志强,陈小可,彭蕻琳.909例胸腔积液病因与诊断分析[J].新医学,2005,36(6):327-328. 被引量:84
  • 4Bielsa S,Esquerda A,Salud A,et al.High levels of tumor markers in pleural fluid correlate with poor survival in patients with adenocarcinomatous or squamous malignant effusions.Eur J Intern Med,2009,20(4):383-386.
  • 5McGrath EE,David W,Anderson PB.The use of non-routine pleural fluid analysis in the diagnosis of pleural effusion.RESPIRATORY MEDICINE.2010,104(8):1092-1100.
  • 6方雷,汪世存.^(18)FDG-PET在肺癌诊断中的应用价值[J].临床肺科杂志,2009,14(2):210-212. 被引量:4
  • 7王全师,吴湖炳,王明芳,王欣璐,郭晓君.PET/CT显像在肺癌诊断及分期中的初步应用[J].中华核医学杂志,2005,25(2):75-77. 被引量:32
  • 8Stathopoulos GT.Translational advances in pleural malignancies[M].RESPIROLOGY.2011,16(1):53-63.
  • 9Kim BS,Kim IJ,Kim SJ,et al.Predictive Value of F-18FDG PET/CT for Malignant Pleural Effusion in Non-Small Cell Lung Cancer Patients[M].ONKOLOGIE.2011,34(6):298-343.
  • 10Liao Nai-Ding,Shieh Jiunn-Min,Lee Wen-Ying.Diagnostic Value of Metabolic Phenotypes in Malignant Pleural Effusions Expression of GLUT1 and CAIX by Immunocytochemistry[J].CANCER CYTOPATHOLOGY.2011,119(5):346-353.

二级参考文献30

  • 1Bunyaviroch T, Coleman RE. PET evaluation of lung cancer. J Nucl Med, 2006,47 ( 3 ) :451 - 69.
  • 2Erasmus JJ, McAdams HP, Connolly JE. Solitary pulmonary nodules: part Ⅱ. Evaluation of the indeterminate nodule. RadioGraphics, 2000,20:59-66.
  • 3Dewan NA, Shehan C J, Reeb SD, et al. Likelihood of malignancy in a solitary pulmonary nodule. Chest, 1997,112:416 - 422.
  • 4Duhaylongsod FG, Lowe V J, Patz EF Jr, et al. Detection of primary and recurrent lung cancer by means of F-18fluorodeoxyglucose positron emission tomography (FDG PET). J Thorac Cardiovasc Surg, 1995,110 : 130 - 139.
  • 5Henschke CI, Yankelevitz DF, Naidich DP, et al. CT screening for lung cancer: suspiciousness of nodules according to size on baseline scans. Radiology ,2004,231 : 164 - 168.
  • 6Lardinois D, Weder W, Hany TF, et al. Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med, 2003,348:2500 -2507.
  • 7Birin O, Kaappetein AP, Bogers AL, et al. Meta-analysis of positron emission tomography and computed tomographyic imaging indetected mediastinal lymph node metastases in nonsmall cell lung cancer. Ann Thora surg, 2005,79:375 - 382.
  • 8Fischer BM, Mortensen J. The future in diagnosis and staging of lung cancer: positron emission tomography. Respiration, 2006,73 (3) :267 -76.
  • 9Erasmus JJ, Patz EF Jr, McAdams HP, et al. Evaluation of adrenal masses in patients with bronchogenic carcinoma using 18F-fluorodeoxyglucose positron emission tomography. A JR, 1997,168 : 1357 - 1360.
  • 10Gayed I, Vu T, Johnson M, et al. Comparison of bone and 2-deoxy-2-[ 18F] fluoro-D-glucose positron emission tomography in the evaluation of bony metastases in lung cancer. Mol Imaging Biol, 2003,5:26 -31.

共引文献115

同被引文献71

引证文献5

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部